Increased generation of ROS by MDSCs, resulting from up-regulation of NADPH oxidase activity, has been described by several groups of researchers using in vitro and in vivo models of experimental tumorigenesis, as well as in patients with cancer [68,69,70,71]. This evidence concerns the gene FMO5 and cancer.